ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980

Agreement Nears On New Guidelines For Center Grants

November 14, 1980

Waldmann, Columbia, Netherland, Receive Bristol-Myers Awards

April 17, 1992

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996